Imperial College London

DrDuncanRogers

Faculty of MedicineNational Heart & Lung Institute

Reader
 
 
 
//

Contact

 

+44 (0)20 7352 8121 ext 3051duncan.rogers

 
 
//

Location

 

G232Guy Scadding BuildingRoyal Brompton Campus

//

Summary

 

Summary

Duncan Rogers is a Reader in Respiratory Pharmacology in the Section of Airway Disease at the National Heart & Lung Institute. He obtained a BSc in Applied Biology from Brunel University and a Post-Graduate Certificate in Education and a PhD in Physiology from the University of London. He is a coordinator of a Respiratory Science BSc module, as well as undertaking undergraduate teaching in a range of disciplines, including Pharmacology and Cell Biology.

Dr Rogers has a long-standing interest in pathophysiological mechanisms underlying lung inflammation in respiratory diseases such as asthma, chronic bronchitis and cystic fibrosis. He has a particular focus on understanding how bronchitis develops in different lung conditions. He has more recent interests in the potential of plant-derived 'phytoceuticals' as therapeutics for respiratory diseases.    

 Dr Rogers is a Fellow of the Society of Biology (formerly Institute of Biology), as well as member and previous Chairman of the British Association for Lung Research, and member of the British Pharmacological Society and The Physiological Society. He has also been a member of the editorial boards of Thorax and the British Journal of Pharmacology, a member of the Public Relations Committee of the Institute of Biology and of the Scientific Committee of the British Lung Foundation.

Publications

Journals

Tildy BE, Rogers DF, 2015, Therapeutic Options for Hydrating Airway Mucus in Cystic Fibrosis, Pharmacology, Vol:95, ISSN:0031-7012, Pages:117-132

Seagrave J, Albrecht HH, Hill DB, et al., 2012, Effects of guaifenesin, N-acetylcysteine, and ambroxol on MUC5AC and mucociliary transport in primary differentiated human tracheal-bronchial cells, Respiratory Research, Vol:13, ISSN:1465-993X

Lai H, Rogers DF, 2010, Mucus hypersecretion in asthma: intracellular signalling pathways as targets for pharmacotherapy, Current Opinion in Allergy and Clinical Immunology, Vol:10, ISSN:1528-4050, Pages:67-76

Lai H, Rogers DF, 2010, New Pharmacotherapy for Airway Mucus Hypersecretion in Asthma and COPD: Targeting Intracellular Signaling Pathways, Journal of Aerosol Medicine and Pulmonary Drug Delivery, Vol:23, ISSN:1941-2711, Pages:219-231

More Publications